{"id":7268,"date":"2025-11-19T08:24:00","date_gmt":"2025-11-19T02:54:00","guid":{"rendered":"https:\/\/lawfultalks3.selfst.art\/glimet-vs-elgimet-bombay-hc-halts-look-alike-diabetes-drug\/"},"modified":"2026-07-21T17:34:46","modified_gmt":"2026-07-21T12:04:46","slug":"glimet-vs-elgimet-bombay-hc-halts-look-alike-diabetes-drug","status":"publish","type":"post","link":"https:\/\/lawfultalks3.selfst.art\/?p=7268","title":{"rendered":"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug"},"content":{"rendered":"\n<p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Justice Sharmila U Deshmukh of the Bombay High Court has delivered a decisive ruling in favor of Laboratories Griffon Pvt. Ltd., restraining the use and sale of the diabetes drug ELGIMET. The court found that the mark &ldquo;ELGIMET&rdquo; was deceptively similar to the registered trademark &ldquo;GLIMET,&rdquo; used by Griffon for its anti-diabetic products since the early 1990s.<\/span><\/span><\/p>\n \n \n \n <p style=\"text-align:center\"><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\"><\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">&nbsp;In her judgment, Justice Deshmukh emphasized that both marks were phonetically and structurally alike, making it likely that an average consumer with simple recall&nbsp; could easily confuse the two.<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Facts:<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">The issue started when Griffon found ELGIMET products being sold online in June 2024 and decided to seek legal protection. The court granted an ad-interim injunction in September 2024, and it has now been confirmed. Adwin Pharma, which makes ELGIMET, argued that the two marks were neither visually nor phonetically similar, that their price difference would stop buyers from getting confused, and that &ldquo;GLIMET&rdquo; could not be monopolized because it comes from the names of pharmaceutical ingredients. The company also said it adopted the name &ldquo;ELGIMET&rdquo; honestly, as it was connected to its own name, Elcliff.<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Court Reasoning &amp; Ruling:<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">However, the court rejected these arguments, citing the landmark case of Cadila Healthcare Ltd. v. Cadila Pharmaceuticals Ltd., and stressed that confusion in pharmaceutical goods demands stricter scrutiny. It added&nbsp; that prescription-only sales do not fully remove the chance of confusion.<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">&nbsp;Justice Deshmukh observed, &ldquo;The Plaintiffs being in the pharmaceutical industry since the year 1992, the Defendant No 2 ought to have been aware of the Plaintiff&#39;s registered trade mark being in existence and avoided adoption of deceptively similar trade mark. The mere existence of slightest probability of confusion in the case of medicinal products require that the use of the product be restrained.&rdquo;<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">The court further highlighted&nbsp; that Griffon&rsquo;s trademarks were registered in Part A of the old Trade and Merchandise Marks Act, 1958, which showed that they were distinctive. It rejected the argument that &ldquo;GLIMET&rdquo; simply described the drug&rsquo;s ingredients, stating that although no one can claim exclusive rights over the names of individual ingredients, they can claim exclusivity over the coined term &ldquo;GLIMET.&rdquo;<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Adwin Pharma could not show any proof of significant investment, actual sales, or earlier use of the disputed mark. Regarding the passing-off claim, the court held that although Griffon had shown goodwill and reputation, it had not shown a basic case of misrepresentation. Therefore, the court refused to grant interim relief for passing off.<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Ultimately, the ad-interim injunction was confirmed, restraining Adwin Pharma and associated entities from using &ldquo;ELGIMET&rdquo; or any mark identical or deceptively similar to &ldquo;GLIMET&rdquo; or &ldquo;GLIMET DS.&rdquo;<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Appearance&nbsp;<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Advocate For Plaintiff: Adv. Rashmin Khandekar, Adv. Archita Gharat, Adv. Kiran Mehta instructed by Adv.&nbsp; Kiran J Mehta<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Advocate for Defendant: Advocate Bhavi Gada instructed by Advocates Pooja Jain for Defendant Nos. 1, 1A and 1B (through VC); Advocates Rajiv Gupta instructed by&nbsp; Advocates Nisha Kaba, Abhijit Singh, Shivani Upadhyay for Defendant No. 2<\/span><\/span><\/p>\n \n \n \n <p><span style=\"font-size:16px\"><span style=\"font-family:Georgia,serif\">Case Details :&nbsp;&nbsp;<a href=\"https:\/\/drive.google.com\/file\/d\/1xV4PCmoYlYsLhApc9sdMcWEuYsLua1uy\/view?usp=drivesdk\">Laboratories Griffon Pvt. Ltd. and Anr v. Adwin Pharma and Anr. (IA (L)- 27480\/2024 IN COMMERCIAL SUIT IP SUIT NO.225\/2024<\/a><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Justice Sharmila U Deshmukh of the Bombay High Court has delivered a decisive ruling in favor of Laboratories Griffon Pvt. Ltd., restraining the use and sale of the diabetes drug ELGIMET. The court found that the mark &ldquo;ELGIMET&rdquo; was deceptively similar to the registered trademark &ldquo;GLIMET,&rdquo; used by Griffon for its anti-diabetic products since the [&hellip;]<\/p>\n","protected":false},"author":97,"featured_media":9452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[28],"tags":[],"class_list":["post-7268","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-high-courts"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug - Lawful Talks<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug\" \/>\n<meta property=\"og:description\" content=\"Justice Sharmila U Deshmukh of the Bombay High Court has delivered a decisive ruling in favor of Laboratories Griffon Pvt. Ltd., restraining the use and sale of the diabetes drug ELGIMET. The court found that the mark &ldquo;ELGIMET&rdquo; was deceptively similar to the registered trademark &ldquo;GLIMET,&rdquo; used by Griffon for its anti-diabetic products since the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lawfultalks3.selfst.art\/?p=7268\" \/>\n<meta property=\"og:site_name\" content=\"Lawful Talks\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-19T02:54:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-21T12:04:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/07\/556168317e3c96b46126a9f30d463e2f_2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"850\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anam Sayyed\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anam Sayyed\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268\"},\"author\":{\"name\":\"Anam Sayyed\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#\\\/schema\\\/person\\\/f3962cb381e0dbe247ceeac08e3aab58\"},\"headline\":\"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug\",\"datePublished\":\"2025-11-19T02:54:00+00:00\",\"dateModified\":\"2026-07-21T12:04:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268\"},\"wordCount\":548,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/556168317e3c96b46126a9f30d463e2f_2.jpeg\",\"articleSection\":[\"High Courts\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268\",\"url\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268\",\"name\":\"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug - Lawful Talks\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/556168317e3c96b46126a9f30d463e2f_2.jpeg\",\"datePublished\":\"2025-11-19T02:54:00+00:00\",\"dateModified\":\"2026-07-21T12:04:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#primaryimage\",\"url\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/556168317e3c96b46126a9f30d463e2f_2.jpeg\",\"contentUrl\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/556168317e3c96b46126a9f30d463e2f_2.jpeg\",\"width\":850,\"height\":650},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?p=7268#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#website\",\"url\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/\",\"name\":\"Lawful Talks\",\"description\":\"Trusted Legal News and Thoughtful Analysis.\",\"publisher\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#organization\",\"name\":\"Lawful Talks\",\"url\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/open-graph-image-lawful-talks.jpg\",\"contentUrl\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/open-graph-image-lawful-talks.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Lawful Talks\"},\"image\":{\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/#\\\/schema\\\/person\\\/f3962cb381e0dbe247ceeac08e3aab58\",\"name\":\"Anam Sayyed\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/176eeccba81bcf7bb3474ec955301f14eeacfcb660c60d993eddbb5494899b99?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/176eeccba81bcf7bb3474ec955301f14eeacfcb660c60d993eddbb5494899b99?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/176eeccba81bcf7bb3474ec955301f14eeacfcb660c60d993eddbb5494899b99?s=96&d=blank&r=g\",\"caption\":\"Anam Sayyed\"},\"url\":\"https:\\\/\\\/lawfultalks3.selfst.art\\\/?author=97\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug - Lawful Talks","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_GB","og_type":"article","og_title":"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug","og_description":"Justice Sharmila U Deshmukh of the Bombay High Court has delivered a decisive ruling in favor of Laboratories Griffon Pvt. Ltd., restraining the use and sale of the diabetes drug ELGIMET. The court found that the mark &ldquo;ELGIMET&rdquo; was deceptively similar to the registered trademark &ldquo;GLIMET,&rdquo; used by Griffon for its anti-diabetic products since the [&hellip;]","og_url":"https:\/\/lawfultalks3.selfst.art\/?p=7268","og_site_name":"Lawful Talks","article_published_time":"2025-11-19T02:54:00+00:00","article_modified_time":"2026-07-21T12:04:46+00:00","og_image":[{"width":850,"height":650,"url":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/07\/556168317e3c96b46126a9f30d463e2f_2.jpeg","type":"image\/jpeg"}],"author":"Anam Sayyed","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Anam Sayyed","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#article","isPartOf":{"@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268"},"author":{"name":"Anam Sayyed","@id":"https:\/\/lawfultalks3.selfst.art\/#\/schema\/person\/f3962cb381e0dbe247ceeac08e3aab58"},"headline":"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug","datePublished":"2025-11-19T02:54:00+00:00","dateModified":"2026-07-21T12:04:46+00:00","mainEntityOfPage":{"@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268"},"wordCount":548,"commentCount":0,"publisher":{"@id":"https:\/\/lawfultalks3.selfst.art\/#organization"},"image":{"@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#primaryimage"},"thumbnailUrl":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/07\/556168317e3c96b46126a9f30d463e2f_2.jpeg","articleSection":["High Courts"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lawfultalks3.selfst.art\/?p=7268#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268","url":"https:\/\/lawfultalks3.selfst.art\/?p=7268","name":"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug - Lawful Talks","isPartOf":{"@id":"https:\/\/lawfultalks3.selfst.art\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#primaryimage"},"image":{"@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#primaryimage"},"thumbnailUrl":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/07\/556168317e3c96b46126a9f30d463e2f_2.jpeg","datePublished":"2025-11-19T02:54:00+00:00","dateModified":"2026-07-21T12:04:46+00:00","breadcrumb":{"@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lawfultalks3.selfst.art\/?p=7268"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#primaryimage","url":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/07\/556168317e3c96b46126a9f30d463e2f_2.jpeg","contentUrl":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/07\/556168317e3c96b46126a9f30d463e2f_2.jpeg","width":850,"height":650},{"@type":"BreadcrumbList","@id":"https:\/\/lawfultalks3.selfst.art\/?p=7268#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lawfultalks3.selfst.art\/"},{"@type":"ListItem","position":2,"name":"\u201cGLIMET\u201d vs \u201cELGIMET\u201d: Bombay HC Halts Look-Alike Diabetes Drug"}]},{"@type":"WebSite","@id":"https:\/\/lawfultalks3.selfst.art\/#website","url":"https:\/\/lawfultalks3.selfst.art\/","name":"Lawful Talks","description":"Trusted Legal News and Thoughtful Analysis.","publisher":{"@id":"https:\/\/lawfultalks3.selfst.art\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lawfultalks3.selfst.art\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/lawfultalks3.selfst.art\/#organization","name":"Lawful Talks","url":"https:\/\/lawfultalks3.selfst.art\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/lawfultalks3.selfst.art\/#\/schema\/logo\/image\/","url":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/04\/open-graph-image-lawful-talks.jpg","contentUrl":"https:\/\/lawfultalks3.selfst.art\/wp-content\/uploads\/2026\/04\/open-graph-image-lawful-talks.jpg","width":1200,"height":630,"caption":"Lawful Talks"},"image":{"@id":"https:\/\/lawfultalks3.selfst.art\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lawfultalks3.selfst.art\/#\/schema\/person\/f3962cb381e0dbe247ceeac08e3aab58","name":"Anam Sayyed","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/176eeccba81bcf7bb3474ec955301f14eeacfcb660c60d993eddbb5494899b99?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/176eeccba81bcf7bb3474ec955301f14eeacfcb660c60d993eddbb5494899b99?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/176eeccba81bcf7bb3474ec955301f14eeacfcb660c60d993eddbb5494899b99?s=96&d=blank&r=g","caption":"Anam Sayyed"},"url":"https:\/\/lawfultalks3.selfst.art\/?author=97"}]}},"_links":{"self":[{"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/posts\/7268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/users\/97"}],"replies":[{"embeddable":true,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7268"}],"version-history":[{"count":1,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/posts\/7268\/revisions"}],"predecessor-version":[{"id":9451,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/posts\/7268\/revisions\/9451"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=\/wp\/v2\/media\/9452"}],"wp:attachment":[{"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7268"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7268"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lawfultalks3.selfst.art\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}